Budget vs premium
Gala vs Novi: Which Costs Less Over 12 Months? (2026)
Gala or Novi? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Gala and Novi side by side and the marketing reads almost identically. The programs underneath do not.
Gala costs 87% more per month than Novi once promotional pricing is out of the picture ($249/mo against $133/mo). Over a year that gap compounds into real money, and the question is what it buys.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Novi — $1,596 against $2,148 at Gala, on each provider's own best published pricing.
- Most support for the money
- Gala — Provider check-ins and dose monitoring included.
- Tirzepatide access
- Novi — Tirzepatide at $166/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Gala — Neither publishes financing; both expect the full amount monthly.
The short version: Gala vs Novi
The rows below are the ones that differ enough between these two to be worth your attention.
| Gala | Novi | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | Semaglutide from $133/mo, tirzepatide from $166/mo |
| Rate after promotions | $249/mo | $133/mo |
| Pricing structure | Cheaper per month the longer you commit | Published rate per medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Fully online, no in-office visits | Online intake |
| State coverage | Not published | Not published |
| Patient reviews | 2,870 | 50,124 |
| eRxDoctor score | 7.7/10 | 7.0/10 |
What Gala and Novi actually cost over a year
Comparing entry prices across these two would be actively misleading, because they escalate differently. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Gala | Novi | |
|---|---|---|
| First month | $249 | $133 |
| Months 2 onward | $249/mo | $133/mo |
| 6-month total | $1,494 | $798 |
| 12-month total | $2,988 | $1,596 |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
Over a year that is a $552 difference, in Novi's favor. Whether it is the right call depends on whether Gala gives you $46 a month of something you will use.
Is Gala worth the premium?
Before treating the cheaper option as the obvious one, it is worth naming what the more expensive one includes — at Gala that is provider check-ins and dose monitoring included, plus home delivery.
Novi counters with the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166, and the thing it asks you to accept in return: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Price gaps in this market rarely reflect a different molecule; they reflect a different amount of human contact. Decide how much of that you actually intend to use before paying for it.
Inside the Gala program
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery. What it is really selling here is a direct-pay model with dose monitoring included rather than sold as an add-on.
Getting started means fully online, no in-office visits, after which home delivery. Pricing runs on a cheaper per month the longer you commit basis, published upfront.
Ongoing care is provider check-ins and dose monitoring included, and the medication list runs to compounded semaglutide and compounded tirzepatide.
Gala pros
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
- Fully online, no in-office visits required
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
Against Novi specifically, the trade you are making: the entry price sits above most compounded competitors unless you commit to a longer term.
How Novi works
$200 OFF - GLP-1 for $133 Today In this pairing, its distinguishing feature is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166.
Intake is online intake. Fulfillment is free 2-day shipping with every order. The commercial terms are published rate per medication, published upfront.
Support: no long-term contract, cancel anytime. The medications on offer are compounded semaglutide and compounded tirzepatide.
Novi pros
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
- Both compounded semaglutide and tirzepatide available
- Free 2-day shipping included with every order
Novi cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Tirzepatide ($166) costs more than the semaglutide entry rate
- No published outcome or weight loss guarantee
The cost of choosing this over Gala: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Gala or Novi: matching the program to the patient
Choose Gala if:
- you want to start on their timeline: fully online, no in-office visits
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- what it leads on is worth paying for in your case: a direct-pay model with dose monitoring included rather than sold as an add-on
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose Novi if:
- the monthly rate is the constraint — $133/mo against $249/mo
- you want tirzepatide available without changing provider later
- you would rather use the platform with the longer public record (50,124 reviews)
- the twelve-month total is what you are optimizing ($1,596 against $2,988)
The trade-offs, stated plainly
On price. Novi is the cheaper program at $133/mo against $249/mo. What Novi gives up for that is the $133 rate depends on a $200-off promotion and there is no outcome guarantee; what Gala charges for is a direct-pay model with dose monitoring included rather than sold as an add-on.
On commitment. Gala rewards a longer commitment (longer-term plan at $179/mo), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — provider check-ins and dose monitoring included against no long-term contract, cancel anytime — and that difference is felt in week two, not week one.
On medication. Gala covers compounded semaglutide and compounded tirzepatide; Novi covers compounded semaglutide and compounded tirzepatide. Only Novi publishes a tirzepatide route, which matters if semaglutide underdelivers.
Evidence and regulatory status
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Gala vs Novi: common questions
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both Gala and Novi price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
Are Gala and Novi legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Gala operates on cheaper per month the longer you commit with pricing published upfront, Novi on published rate per medication, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Can I switch from Gala to Novi later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date, and check the refund terms on any prepaid plan first.
Is Gala or Novi better for a first GLP-1 prescription?
For a first prescription, weight support over price. Gala offers more contact (provider check-ins and dose monitoring included), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
Do Gala and Novi prescribe the same medication?
Both dispense compounded GLP-1 preparations. Gala lists compounded semaglutide and compounded tirzepatide and Novi lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
The verdict
Strictly on cost, Novi takes it — $1,596 to $2,148 over twelve months.
Gala earns the difference in one situation: when a direct-pay model with dose monitoring included rather than sold as an add-on is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Gala vs He & She MDCoaching-supported vs medication-only
- Gala vs MaximusBudget vs premium
- Novi vs Elevate HealthSame price, different service model
- Novi vs TMatesTirzepatide access
- TrimRx vs JoinFridaysBudget vs premium
- TrimRx vs MedViBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or Novi, and does not sell treatment. Read our ranking methodology.